These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25462800)

  • 1. Effects of estrogen and testosterone treatment on serotonin transporter binding in the brain of surgically postmenopausal women--a PET study.
    Jovanovic H; Kocoska-Maras L; Rådestad AF; Halldin C; Borg J; Hirschberg AL; Nordström AL
    Neuroimage; 2015 Feb; 106():47-54. PubMed ID: 25462800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET.
    Jovanovic H; Lundberg J; Karlsson P; Cerin A; Saijo T; Varrone A; Halldin C; Nordström AL
    Neuroimage; 2008 Feb; 39(3):1408-19. PubMed ID: 18036835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women.
    Zang H; Carlström K; Arner P; Hirschberg AL
    Fertil Steril; 2006 Jul; 86(1):136-44. PubMed ID: 16750207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systems.
    Schain M; Tóth M; Cselényi Z; Stenkrona P; Halldin C; Farde L; Varrone A
    Neuroimage; 2012 Mar; 60(1):800-7. PubMed ID: 22227138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of 11C-MADAM binding to the serotonin transporter in the human brain.
    Lundberg J; Odano I; Olsson H; Halldin C; Farde L
    J Nucl Med; 2005 Sep; 46(9):1505-15. PubMed ID: 16157534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hormone replacement therapy on cerebral serotonin-1A receptor binding in postmenopausal women examined with [carbonyl-¹¹C]WAY-100635.
    Kranz GS; Rami-Mark C; Kaufmann U; Baldinger P; Hahn A; Höflich A; Savli M; Stein P; Wadsak W; Mitterhauser M; Winkler D; Lanzenberger R; Kasper S
    Psychoneuroendocrinology; 2014 Jul; 45():1-10. PubMed ID: 24845171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of serotonin transporter binding with PET and [11C]MADAM: a test-retest reproducibility study.
    Lundberg J; Halldin C; Farde L
    Synapse; 2006 Sep; 60(3):256-63. PubMed ID: 16752362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET.
    Halldin C; Lundberg J; Sóvágó J; Gulyás B; Guilloteau D; Vercouillie J; Emond P; Chalon S; Tarkiainen J; Hiltunen J; Farde L
    Synapse; 2005 Dec; 58(3):173-83. PubMed ID: 16138320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being.
    Flöter A; Nathorst-Böös J; Carlström K; von Schoultz B
    Climacteric; 2002 Dec; 5(4):357-65. PubMed ID: 12626215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the distribution of serotonin transporter in the human brainstem with high-resolution PET: Validation using postmortem autoradiography data.
    Fazio P; Schain M; Varnäs K; Halldin C; Farde L; Varrone A
    Neuroimage; 2016 Jun; 133():313-320. PubMed ID: 26994829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses.
    Sarrel P; Dobay B; Wiita B
    J Reprod Med; 1998 Oct; 43(10):847-56. PubMed ID: 9800666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Dose Testosterone Treatment Increases Serotonin Transporter Binding in Transgender People.
    Kranz GS; Wadsak W; Kaufmann U; Savli M; Baldinger P; Gryglewski G; Haeusler D; Spies M; Mitterhauser M; Kasper S; Lanzenberger R
    Biol Psychiatry; 2015 Oct; 78(8):525-33. PubMed ID: 25497691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of estradiol versus estradiol and testosterone on brain-activation patterns in postmenopausal women.
    Archer JS; Love-Geffen TE; Herbst-Damm KL; Swinney DA; Chang JR
    Menopause; 2006; 13(3):528-37. PubMed ID: 16735951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of testosterone and estrogen treatment on the distribution of sex hormone receptors in the endometrium of postmenopausal women.
    Zang H; Sahlin L; Masironi B; Hirschberg AL
    Menopause; 2008; 15(2):233-9. PubMed ID: 18030175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.
    Shifren JL; Braunstein GD; Simon JA; Casson PR; Buster JE; Redmond GP; Burki RE; Ginsburg ES; Rosen RC; Leiblum SR; Caramelli KE; Mazer NA
    N Engl J Med; 2000 Sep; 343(10):682-8. PubMed ID: 10974131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2).
    Nogami T; Takano H; Arakawa R; Ichimiya T; Fujiwara H; Kimura Y; Kodaka F; Sasaki T; Takahata K; Suzuki M; Nagashima T; Mori T; Shimada H; Fukuda H; Sekine M; Tateno A; Takahashi H; Ito H; Okubo Y; Suhara T
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):937-43. PubMed ID: 23067569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temperament, character and serotonin activity in the human brain: a positron emission tomography study based on a general population cohort.
    Tuominen L; Salo J; Hirvonen J; Någren K; Laine P; Melartin T; Isometsä E; Viikari J; Cloninger CR; Raitakari O; Hietala J; Keltikangas-Järvinen L
    Psychol Med; 2013 Apr; 43(4):881-94. PubMed ID: 22850434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular imaging of the serotonin transporter availability and occupancy by antidepressant treatment in late-life depression.
    Smith GS; Kuwabara H; Gould NF; Nassery N; Savonenko A; Joo JH; Bigos KL; Kraut M; Brasic J; Holt DP; Hall AW; Mathews WB; Dannals RF; Nandi A; Workman CI
    Neuropharmacology; 2021 Aug; 194():108447. PubMed ID: 33450276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography study.
    Hinderberger P; Rullmann M; Drabe M; Luthardt J; Becker GA; Blüher M; Regenthal R; Sabri O; Hesse S
    Neuropharmacology; 2016 Nov; 110(Pt A):530-536. PubMed ID: 27108933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.